Log In
Print
BCIQ
Print
Print this Print this
 

XmAb5485

  Manage Alerts
Collapse Summary General Information
Company Xencor Inc.
DescriptionHumanized mAb against CD40 with affinity for Fc gamma receptor
Molecular Target CD40
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL) and multiple myeloma (MM)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today